Cost-effectiveness of transdiagnostic group cognitive behavioural therapy for anxiety disorders v. treatment as usual: economic evaluation of a pragmatic randomized controlled trial over an 8-month time horizon using self-reported data.

MLA

Chapdelaine, Alexandra, et al. “Cost-Effectiveness of Transdiagnostic Group Cognitive Behavioural Therapy for Anxiety Disorders v. Treatment as Usual: Economic Evaluation of a Pragmatic Randomized Controlled Trial over an 8-Month Time Horizon Using Self-Reported Data.” Psychological Medicine, vol. 53, no. 14, Oct. 2023, pp. 6570–82. EBSCOhost, https://doi.org/10.1017/S0033291722003920.

APA

Chapdelaine, A., Vasiliadis, H.-M., Provencher, M. D., Norton, P. J., & Roberge, P. (2023). Cost-effectiveness of transdiagnostic group cognitive behavioural therapy for anxiety disorders v. treatment as usual: economic evaluation of a pragmatic randomized controlled trial over an 8-month time horizon using self-reported data. Psychological Medicine, 53(14), 6570–6582. https://doi.org/10.1017/S0033291722003920

Chicago

Chapdelaine, Alexandra, Helen-Maria Vasiliadis, Martin D. Provencher, Peter J. Norton, and Pasquale Roberge. 2023. “Cost-Effectiveness of Transdiagnostic Group Cognitive Behavioural Therapy for Anxiety Disorders v. Treatment as Usual: Economic Evaluation of a Pragmatic Randomized Controlled Trial over an 8-Month Time Horizon Using Self-Reported Data.” Psychological Medicine 53 (14): 6570–82. doi:10.1017/S0033291722003920.